Outset Medical Named to Fast Company’s First-Ever List of the Next Big Things in Tech
18 Novembre 2021 - 2:47PM
Business Wire
New Recognition Program Highlights Tech
Breakthroughs That Promise to Define the Future of Their
Industries
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical
technology company pioneering a first-of-its-kind technology to
reduce the cost and complexity of dialysis, today announced that it
has been named to Fast Company’s inaugural Next Big Things in Tech
list, honoring the technology breakthroughs that promise to shape
the future of their industries — from healthcare to agriculture to
artificial intelligence and more.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20211118005835/en/
Outset Medical Named to Fast Company’s
List of the Next Big Things in Tech (Graphic: Business Wire)
Outset is reinventing how dialysis is delivered to patients.
Specifically designed to simplify dialysis treatment for patients
and providers, the Tablo® Hemodialysis System is a
first-of-its-kind enterprise solution that is approved for use
across the entire continuum of care — from hospital to home.
Representing a significant technological advancement, Tablo
transforms the dialysis experience for patients and operationally
simplifies it for providers. Tablo is an all-in-one dialysis
machine that combines consumer product simplicity, wireless
connectivity, and real-time integrated water purification in one,
compact 35-inch unit. It is easy to learn and use, offering
flexible, intelligent dialysis that lowers costs and improves the
patient experience.
“It’s an honor to be selected by Fast Company for this
prestigious list. It’s a testament to the imagination and
perseverance our team applies every day to transforming the
dialysis experience,” said Leslie Trigg, President and Chief
Executive Officer of Outset. “From the beginning, we took a
consumer-centric approach to Tablo to ensure anyone would be
capable of using it anytime, virtually anywhere. We will continue
to innovate until all patients are able to dialyze to live instead
of living to dialyze.”
“Fast Company is thrilled to highlight cutting-edge technologies
that are solving real-world problems in unexpected ways. From
climate change and public health crises to machine learning and
security, these technologies will certainly have a profound impact
on the future, and we’re honored to bring attention to them today,”
says Stephanie Mehta, editor-in-chief of Fast Company.
The final list, which includes global giants, intrepid startups,
and research that’s fresh from the labs, recognizes 65 technologies
that are making waves. While not all of the products, services, and
technological developments are on the market yet, they’re reaching
key milestones in having a positive impact for consumers,
businesses, and society at large in the next five years. Fast
Company also recognized 33 honorable mentions. Click here to see
the final list.
The Winter 2021/2022 issue of Fast Company is available online
now and will hit newsstands on December 7.
About Outset Medical, Inc.
Outset is a medical technology company pioneering a
first-of-its-kind technology to reduce the cost and complexity of
dialysis. The Tablo® Hemodialysis System, FDA cleared for use from
the hospital to the home, represents a significant technological
advancement that transforms the dialysis experience for patients
and operationally simplifies it for providers. Tablo serves as a
single enterprise solution that can be utilized across the
continuum of care, allowing dialysis to be delivered anytime,
anywhere and by anyone. The integration of water purification and
on-demand dialysate production enables Tablo to serve as a dialysis
clinic on wheels, with 2-way wireless data transmission and a
proprietary data analytics platform powering a new holistic
approach to dialysis care. Tablo is a registered trademark of
Outset Medical, Inc.
About Fast Company
Fast Company is the only media brand fully dedicated to the
vital intersection of business, innovation, and design, engaging
the most influential leaders, companies, and thinkers on the future
of business. The editor-in-chief is Stephanie Mehta. Headquartered
in New York City, Fast Company is published by Mansueto Ventures
LLC, along with our sister publication, Inc., and can be found
online at fastcompany.com.
Forward-Looking Statements
This press release may contain forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. These statements include statements regarding Outset’s
strategy, plans and objectives. Forward-looking statements are
inherently subject to risks and uncertainties, some of which cannot
be predicted or quantified, which could cause actual results and
other events to differ materially from those expressed or implied
in such statements. These risks and uncertainties include risks
described in the Risk Factors section of Outset’s most recent
annual report on Form 10-K and quarterly report on Form 10-Q filed
with the U.S. Securities and Exchange Commission. These
forward-looking statements speak only as of the date hereof and
should not be unduly relied upon. Outset disclaims any obligation
to update these forward-looking statements.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211118005835/en/
Nicole Shannon Director, Marketing Communications for Outset
Medical nshannon@outsetmedical.com
Grupo Aeroportuario del ... (NASDAQ:OMAB)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Grupo Aeroportuario del ... (NASDAQ:OMAB)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025
